Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03081656
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
BD4 | 6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4- C]CARBAZOLE-1,3(2H,6H)-DIONE | A | 1WVX | 0.73 | |
UCM | REL-(9R,12S)-9,10,11,12-TETRAHYDRO- 9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'- KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE- 1,3(2H)-DIONE | A | 1NVS | 0.85 | |
CM7 | N-[(1S,2R)-1-benzyl-2-hydroxy-3- {[3-(trifluoromethyl)benzyl]amino}propyl]- 7-ethyl-1-methyl-3,4-dihydro-1H- [1,2,5]thiadiazepino[3,4,5-hi]indole- 9-carboxamide 2,2-dioxide | A | 2VNN | 0.73 | |
THX | A | 1AUL | 0.72 | ||
UCN | 7-HYDROXYSTAUROSPORINE | A | 1OKZ | 0.84 | |
UCN | 7-HYDROXYSTAUROSPORINE | A,C | 1PKD | 0.84 | |
UCN | 7-HYDROXYSTAUROSPORINE | A | 1NVQ | 0.84 | |
FRN | A | 2CV3 | 0.71 | ||
STU | STAUROSPORINE | A,B | 3CBL | 0.86 | |
STU | STAUROSPORINE | A | 1QPJ | 0.86 | |
STU | STAUROSPORINE | A,B | 3CD3 | 0.86 | |
STU | STAUROSPORINE | A | 2ITU | 0.86 | |
STU | STAUROSPORINE | A,B | 2BUJ | 0.86 | |
STU | STAUROSPORINE | A,B | 2CLQ | 0.86 | |
STU | STAUROSPORINE | A | 1XBC | 0.86 | |
STU | STAUROSPORINE | A | 2ITW | 0.86 | |
STU | STAUROSPORINE | A | 1E8Z | 0.86 | |
STU | STAUROSPORINE | A | 1YHS | 0.86 | |
STU | STAUROSPORINE | A,B | 3D7T | 0.86 | |
STU | STAUROSPORINE | A | 1QPD | 0.86 | |
STU | STAUROSPORINE | A | 2Z7R | 0.86 | |
STU | STAUROSPORINE | A,B,C,D | 2NRY | 0.86 | |
STU | STAUROSPORINE | A | 1U59 | 0.86 | |
STU | STAUROSPORINE | A | 1NVR | 0.86 | |
STU | STAUROSPORINE | A,B,C,D | 2OIC | 0.86 | |
STU | STAUROSPORINE | A | 1AQ1 | 0.86 | |
STU | STAUROSPORINE | A | 1BYG | 0.86 | |
STU | STAUROSPORINE | A,B | 1SM2 | 0.86 | |
STU | STAUROSPORINE | X | 2DQ7 | 0.86 | |
STU | STAUROSPORINE | A | 3CKX | 0.86 | |
STU | STAUROSPORINE | A,B | 1Q3D | 0.86 | |
STU | STAUROSPORINE | E | 1STC | 0.86 | |
STU | STAUROSPORINE | A | 1OKY | 0.86 | |
STU | STAUROSPORINE | A | 1WVY | 0.86 | |
STU | STAUROSPORINE | A | 2HW7 | 0.86 | |
STU | STAUROSPORINE | A,B | 1SNU | 0.86 | |
STU | STAUROSPORINE | A | 2ITQ | 0.86 | |
STU | STAUROSPORINE | A,B,C,D | 1NXK | 0.86 | |
STU | STAUROSPORINE | A | 3BKB | 0.86 | |
STU | STAUROSPORINE | A | 1XJD | 0.86 | |
STU | STAUROSPORINE | A | 3FME | 0.86 | |
STU | STAUROSPORINE | A,B | 2GCD | 0.86 | |
STU | STAUROSPORINE | A,B,C | 2PZY | 0.86 | |
XDR | hexyl (5S,6R,8R)-6-hydroxy-5-methyl- 13-oxo-5,6,7,8-tetrahydro-13H-5,8- epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4- jkl]cyclopenta[e]-as-indacene-6- carboxylate | A,B | 3F69 | 0.94 | |
IPF | N-ACETYLTRYPTOPHYL-N~1~-{3-[1-(N- ACETYLTRYPTOPHYLVALYL)PYRROLIDIN- 2-YL]-1-BENZYL-2,3-DIHYDROXYPROPYL}VALINAMIDE | A,B | 2A1E | 0.71 | |
LY4 | (9R)-9-[(DIMETHYLAMINO)METHYL]- 6,7,10,11-TETRAHYDRO-9H,18H-5,21:12,17- DIMETHENODIBENZO[E,K]PYRROLO[3,4- H][1,4,13]OXADIAZACYCLOHEXADECINE- 18,20-DIONE | B | 2J2I | 0.71 | |
LY4 | (9R)-9-[(DIMETHYLAMINO)METHYL]- 6,7,10,11-TETRAHYDRO-9H,18H-5,21:12,17- DIMETHENODIBENZO[E,K]PYRROLO[3,4- H][1,4,13]OXADIAZACYCLOHEXADECINE- 18,20-DIONE | A | 1UU3 | 0.71 | |
FLL | OCTAHEDRAL RU-PYRIDOCARBAZOLE | A | 3FXZ | 0.7 | |
1ST | (5S,6R,7R,9R)-12-HYDROXY-6-METHOXY- 5-METHYL-7-(METHYLAMINO)-6,7,8,9- TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15- TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4- JKL]CYCLOPENTA[E]-AS-INDACEN-14- ONE | 1 | 2HY8 | 0.77 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A | 2J0J | 0.86 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | B | 2J0M | 0.86 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A,B | 2J0K | 0.86 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A | 1YVJ | 0.86 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A,B,C | 2HZ4 | 0.86 | |
K2C | 6,7,12,13-tetrahydro-5H-indolo[2,3- a]pyrrolo[3,4-c]carbazol-5-one | A | 2R0P | 0.75 | |
ZY4 | N-[(1S)-1-BENZYL-2,2-DIHYDROXY- 3-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PROPYL]- 6-ETHYL-1-METHYL-1,3,4,6-TETRAHYDRO[1,2]THIAZEPINO[5,4,3- CD]INDOLE-8-CARBOXAMIDE 2,2-DIOXIDE | A | 2WF4 | 0.71 | |
HR1 | (3R,5R)-7-[1-(4-FLUOROPHENYL)-3- ISOPROPYL-4-OXO-5-PHENYL-4,5-DIHYDRO- 3H-PYRROLO[2,3-C]QUINOLIN-2-YL]- 3,5-DIHYDROXYHEPTANOIC ACID | A,B,C,D | 2Q6C | 0.71 | |
396 | 4-(2-chlorophenyl)-9-hydroxy-6- methyl-1,3-dioxo-N-(2-pyrrolidin- 1-ylethyl)pyrrolo[3,4-g]carbazole- 8-carboxamide | A | 3BI6 | 0.71 | |
JTP | N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2- D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]- 2-METHYL-L-ALANINE | A,B | 2DXS | 0.71 | |
C80 | (2S,4S,5R,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL 1- BENZYL-1H-INDOLE-3-CARBOXYLATE | C,O | 2V11 | 0.7 | |
KSA | K-252A | A | 1R0P | 0.99 | |
KSA | K-252A | A | 3EQF | 0.99 | |
KAW | N-{(5S)-4,4-dihydroxy-6-phenyl- 5-[(phenylcarbonyl)amino]hexanoyl}- L-tryptophan | A | 3BKL | 0.7 | |
DFN | 3-[3-(2,3-DIHYDROXY-PROPYLAMINO)- PHENYL]-4-(5-FLUORO-1-METHYL-1H- INDOL-3-YL)-PYRROLE-2,5-DIONE | A,B | 1R0E | 0.7 | |
SA3 | 2,10-DIHYDROXY-12-(BETA-D-GLUCOPYRANOSYL)- 6,7,12,13-TETRAHYDROINDOLO[2,3- A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE | A,C,D | 1SEU | 0.76 | |
CMF | 3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL- 2-OXOETHYL)-2-PHENYL-1H-INDOLE- 6-CARBOXYLIC ACID | A | 2BRK | 0.72 | |
ME3 | RUTHENIUM-PYRIDOCARBAZOLE-3 | A | 2BZJ | 0.71 | |
HR2 | (3R,5R)-7-[3-(4-FLUOROPHENYL)-1- ISOPROPYL-8-OXO-7-PHENYL-1,4,5,6,7,8- HEXAHYDROPYRROLO[2,3-C]AZEPIN-2- YL]-3,5-DIHYDROXYHEPTANOIC ACID | A,B,C,D | 2Q6B | 0.7 | |
839 | 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL- 2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL- 6(1H)-YL)PROPANOIC ACID | A | 2IN6 | 0.73 | |
SNX | 2-[(2-methoxyethyl)amino]-4-(4- oxo-1,2,3,4-tetrahydro-9H-carbazol- 9-yl)benzamide | A | 3D0B | 0.7 | |
AG1 | RUTHENIUM PYRIDOCARBAZOLE | A,B | 2JLD | 0.74 |